In This Week’s Issue:
 
1. PIPC Joins 30 Leading Disability and Civil Rights Stakeholders in Letter Asking HHS to Step Up Nondiscrimination Efforts, click here to read the letter.
2. Chairman's Corner: CBO Confirms Use of Discriminatory Metrics in H.R. 3, see details below.
3. PIPC Congratulates Andy Imparato on Appointment to COVID-19 Health Equity Task Force, click here to view the announcement.
4. Emerging Threats in States for Use of Discriminatory Metrics, see details below.
5. 2021 AUCD Virtual Gala, click here to learn more and register.
6. EveryLife Foundation for Rare Diseases Report on the Economic Burden of Rare Diseases in America and the Rare on the Road Leadership Tour, see details below.
7. Pharmacy Benefit Managers Push for QALYs in Medicare Despite Implications for Discrimination, see details below.
8. IVI Webinar on Principles for Good Value Assessment, click here to register and to learn more.
9. Vaccination Equity and Communication, see details below.
10. PCORI Seeks Nominations for Advisory Panels, click here to learn more, submit a nomination, or apply to be on an advisory panel.
11. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
12. ICER's QALY-Based Study Topics: Atopic Dermatitis, Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, click here to provide patient input.
13. Upcoming Events and Webinars, see details below.
14. Medical Journal Articles, see details below.
15. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:
 
1. Chairman's Corner: CBO Confirms Use of Discriminatory Metrics in H.R. 3, see details below.
2. PIPC Congratulates Andy Imparato on Appointment to COVID-19 Health Equity Task Force, click here to view the announcement.
3. Emerging Threats in States for Use of Discriminatory Metrics, see details below.
4. Op-Ed: Washington State Bill Includes Group Known for Discriminatory Practices, click here to read the full op-ed.
5. EveryLife Foundation for Rare Diseases Report on the Economic Burden of Rare Diseases in America and the Rare on the Road Leadership Tour, see details below.
6. Op-Ed: The Biden Administration Needs to Look Beyond ICER for Value Assessment, click here to read the op-ed.
7. Pharmacy Benefit Managers Push for QALYs in Medicare Despite Implications for Discrimination, see details below.
8. IVI Webinar on Principles for Good Value Assessment, click here to register and to learn more.
9. Vaccination Equity and Communication, see details below.
10. PCORI Seeks Nominations for Advisory Panels, click here to learn more, submit a nomination, or apply to be on an advisory panel.
11. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
12. ICER's QALY-Based Study Topics: Atopic Dermatitis, Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, click here to provide patient input.
13. Upcoming Events and Webinars, see details below.
14. Medical Journal Articles, see details below.
15. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:
 
1. New CBO Working Paper Confirms How QALYs Used in the 2019 H.R. 3 Bill, see details below.
2. Emerging Threats in States for Use of Discriminatory Metrics, see details below.
3. Pharmacy Benefit Managers Push for QALYs in Medicare Despite Implications for Discrimination, see details below.
4. IVI Webinar on Principles for Good Value Assessment, click here to register and to learn more.
5. 60 Patient and Disability Groups Join PIPC in Comment Letter to HHS Opposing Most Favored Nations Rule, see details below.
6. COVID-19 Response for Vulnerable Patients, see details below.
7. PCORI Seeks Nominations for Advisory Panels, click here to learn more, submit a nomination, or apply to be on an advisory panel.
8. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
9. ICER's QALY-Based Study Topics: Atopic Dermatitis, Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, click here to provide patient input.
10. Upcoming Events and Webinars, see details below.
11. Medical Journal Articles, see details below.
12. AHRQ Effective Program Updates, see details below.  

In This Week’s Issue:
 
1. 60 Patient and Disability Groups Join PIPC in Comment Letter to HHS Opposing Most Favored Nations Rule, see details below.
2. Emerging Threats in States for Use of Discriminatory Metrics, see details below.
3. ICER Hosts Public Meeting for its Assessment of Treatments for High Cholesterol, see details below.
4. IVI Welcomes New Chief Scientific Officer, see details below.
5. NCD Letter on 'Most Favored Nations' Rule, click here to read the letter.
6. COVID-19 Response for Vulnerable Patients, see details below.
7. PCORI Seeks Nominations for Advisory Panels, click here to learn more, submit a nomination, or apply to be on an advisory panel.
8. International News: What Happens in Countries Using QALYs and Cost-Based Thresholds to Determine Coverage? See below for more.
9. ICER's QALY-Based Study Topics: Atopic Dermatitis, Treatments, High Cholesterol, Anemia in Chronic Kidney Disease, Lupus Nephritis, Multiple Myeloma, Alzheimer's Disease, click here to provide patient input.
10. Upcoming Events and Webinars, see details below.
11. Medical Journal Articles, see details below.
12. AHRQ Effective Program Updates, see details below.